Abstract
Sepsis is a clinical syndrome comprising derangements of inflammatory, hemodynamic, metabolic and coagulation systems. Sepsis is frequently complicated by irreversible shock, diffuse intravascular coagulation and multiple organ failure (MOF), and despite of the availability of improved supportive measures in intensive care units, the mortality due to sepsis remains around 40–60% [1].
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Harris RL, Musher DM, Bloom K, et al. (1987) Manifestations of sepsis. Arch Intern Med 147:1895
Hinshaw LB, Brackett DJ, Archer LT, Beller BK, Wilson MF (1983) Detection of the hyper-dynamic state of sepsis in the baboon during lethal E. Coli infusion. J Trauma 23:361–365
Taylor FB, Chang Jr. A, Esmon CT, D’Angelo A, Vigano-D’Angelo S, Blick KE (1987) Protein C prevents the coagulopathic and lethal effects of Escherichia Coli infusion in the baboon. J Clin Invest 79:918–925
Levi M, Ten Cate H, Bauer KA, et al. (1992) Pentoxifylline inhibits endotoxin-induced activation of coagulation and fibrinolysis in a chimpanzee model of endotoxemia. (In press)
Van Deventer SJH, Buller HR, Ten Cate JW, Sturk A, Pauw W (1988) Endoxaemia: An early predictor of septicemia in febrile patients. The Lancet 1:605–609
Brandtzaeg P, Kierulf P, Gaustad P, et al. (1989) Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis 159:195–204
Michie HR, Manogue KR, Spriggs DR, et al. (1988) Detection of circulating tumor necrosis factor after endotoxin administration. New Eng J Med 318:1481–1486
Van Deventer SJH, Buller HR, Ten Cate JW, Aarden LA, Hack CE, Sturk A (1990) Experimental endotoxemia in humans: Analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood 76:2520–2526
Waage A, Halstensen A, Espevik T (1987) Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1:355–357
Hack CE, De Groot ER, Felt-Bersma RJF, et al. (1989) Increased plasma levels of interleukin-6 in sepsis. Blood 74:1704–1710
Waage A, Brandtzaeg P, Halstensen A, Kierulf P, Espevik T (1989) The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between inter-leukin-6, interleukin-1 and fatal outcome. J Exp Med 169:333–338
Fong Y, Tracey KJ, Moldawer LL (1989) Antibodies to cachectin/tumor necrosis factor reduce in-terleukin 1ß and interleukin 6 appearance during lethal bacteremia. J Exp Med 170:1627–1633
Beutler B, Milsark IW, Cerami AC (1985) Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229:869–871
Natanson C, Eichenholz PW, Danner RL, et al. (1989) Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J Exp Med 169:823–832
Bauer KA, Ten Cate H, Barzegar S, Spriggs DR, Sherman ML, Rosenberg RD (1989) Tumor necrosis factor infusions have a procoagulant effect on the hemostatic mechanism of humans. Blood 74:165–172
Van Der Poll T, Buller HR, Ten Cate H, et al. (1990) Activation of coagulation after administration of tumor necrosis factor to normal subjects. New Eng J Med 322:1622–1627
Altieri DC, Morrissey JH, Edgington TS (1988) Adhesive receptor Mac-1 coordinates the activation of factor X on stimulated cells of monocytic and myeloid differentiation: An alternative initiation of the coagulation protein cascade. Proc Natl Acad Sci USA 85:7462–7466
Osterud B, Flaegstad T (1983) Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: Related to unfavourable prognosis. Thromb Haemost 49:5–7
De Boer JP, Creasey AA, Chang A, et al. (1992) Activation of coagulation and fibrinolysis in baboons following infusion with lethal or sublethal dose of E. Coli. (in press)
Taylor FB, Chang A, Ferrel G, et al. (1991) C4b-binding protein exacerbates the host response to Escherichia Coli. Blood 78:357–363
Suffredini AF, Harpel PC, Parillo JE (1989) Promotion and subsequent inhibition of plasmino-gen activator after administration of intraveneous endotoxin to normal subjects. New Eng J Med 320:1165–1172
Van Der Poll T, Levi M, Buller HR, et al. (1991) Fibrinolytic response to tumor necrosis factor in healthy subjects. J Exp Med 174:729–732
Ziegler EJ, Fisher CJ Jr., Sprung CL et al. (1991) Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. New Eng J Med 324:429–436
Tracey KJ, Fong Y, Hesse DG, et al. (1987) Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteremia. Nature: 330:662–664
Hinshaw LB, TeKamp-Olson P, Chang AC, et al. (1990) Survival of primates in LD100 septic shock following therapy with antibody to tumor necrosis factor (TNF alpha). Circ Shock 30:279–292
Strieter RM, Remick DG, Ward PA, et al. (1988) Cellular and molecular regulation of tumor necrosis factor-alfa production by pentoxifylline. Biochem Biophys Res Comm 155:1230–1236
Tighe D, Moss R, Hynd J, et al. (1988) Pentoxifylline reverses haemodynamic and histological changes associated with peritonitis in pigs. In: Mandell GL, Novick J Jr., et al. (eds): Pentoxifylline and leukocyte function. Somerville NJ, HRP Inc. pp 184–189
Zabel P, Wolter DT, Schonharting MM, Schade UF (1989) Oxpentifylline in endotoxemia. The Lancet 2:1474–1477
Levi M, Ten Cate H, Bauer KA, et al. (1991) Dose dependent endotoxin induced cytokine release and coagulation activation in chimpanzees. Thromb Haemostas 65:410 (Abs.)
Okusawa S, Gelfand JA, Ikejima T, Connolly RJ, Dinarello CA (1988) Interleukin-1 induces a shock-like state in rabbits. J Clin Invest 81:1162–1172
Hannum CH, Wilcox CJ, Arend WP, et al. (1990) Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 343:336–340
Eisenberg SP, Evans RJ, Arend WP, et al. (1990) Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 343:341–346
Ohlsson K, Bjork P, Bergenfeldt M, Hageman R, Thompson RC (1990) Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature 348:550–552
Mant MJ, Gartner King E. (1979) Severe, acute disseminated intravascular coagulation. A reappraisal of its pathophysiology, clinical significance and therapy based on 47 patients. Am J Med 67:557–563
Taylor FB Jr., Chang A, Ruf W, et al. (1991) Lethal E. Coli septic shock is prevented by blok-king tissue factor with monoclonal antibody. Circ Shock 33:127–134
Levi M, Ten Cate H, Bauer KA, et al. (1990) Endotoxin induced tumor necrosis factor release and coagulation activation in vivo. Blood 76:1698 (Abs.)
Taylor FB Jr., Emerson TE Jr., Chang AK, Blick KE (1988) Antithrombin HI prevents the lethal effects of E. Coli infusion in baboons. Circ Shock 26:227–235
Taylor FB Jr., Chang ACK, Peer GT, et al. (1991) DEGR-Factor Xa blocks disseminated intravascular coagulation initiated by Escherichia coli without preventing shock or organ damage. Blood 78:364–368
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Biemond, B.J., Levi, M., van Deventer, S.J.H. (1992). The Procoagulant State in Sepsis: Experimental Models and New Modalities for Intervention. In: Lamy, M., Thijs, L.G. (eds) Mediators of Sepsis. Update in Intensive Care and Emergency Medicine, vol 16. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84827-8_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-84827-8_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-84829-2
Online ISBN: 978-3-642-84827-8
eBook Packages: Springer Book Archive